Table 5.
Univariate |
Multivariate |
|||||
---|---|---|---|---|---|---|
Risk factor | HR | HR (95% CI) | p-value | HR | HR (95% CI) | p-value |
Sex | 0.9 | 0.5–1.5 | 0.6 | 1.2 | 0.6–2.2 | 0.6 |
Presence of IBD | 0.9 | 0.5–1.5 | 0.6 | 0.7 | 0.3–1.3 | 0.2 |
Presence of DS | 0.4 | 0.2–0.8 | 0.005 | 0.5 | 0.3–1.1 | 0.09 |
MRS | 1.6 | 1.3–2.0 | <0.001 | 1.7 | 1.3–2.2 | <0.001 |
Late onset | 0.2 | 0.1–0.4 | <0.001 | 0.3 | 0.1–0.5 | <0.001 |
HR: hazard ratio; CI: confidence interval; IBD: inflammatory bowel disease; DS: dominant stenosis; MRS: Mayo risk score
Data show prospective factors for longer survival until liver transplantation or death. In univariate analysis presence of dominant stenosis, MRS and late-onset disease were associated with reduced actuarial survival. In multivariate analysis only MRS and late-onset disease reached significance (p < 0.05).